$24.71
0.502.07%
Last update: Nov 9, 4:00 PM
Collegium Pharmaceutical Inc
COLLNASDAQ
The average analyst price target for Collegium Pharmaceutical is $45.73, 85.1% above the current price. Of 8 analysts, 7 rate it Buy and 1 Hold. Targets range from $28 to $60. The latest change came on Nov 6, 2026, when Piper Sandler lowered its price target on Collegium Pharmaceutical from $43 to $28 and kept a Neutral rating.
Price Target Range — 11 Quarters
Analyst Consensus — 8 Analysts
Rating Trend — Last 9 Months
